Results 91 to 100 of about 100,300 (318)

A Prospective, Multicenter, Open Label Study Investigating the Implementation of a Standardized Algorithm for Coronary CaLcificatiOn With PlaquE Modification Using UltraSound Guidance to Improve Procedural and Clinical Outcomes (CYCLOPES): Design and Rationale of the CYCLOPES Trial

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Introduction Moderate‐to‐severe calcification is present in ~20%–30% of patients undergoing coronary angiography. Coronary lesion modification is often necessary to facilitate optimal stent delivery and expansion, with several dedicated devices now approved for calcium modification before stent implantation. The CYCLOPES study aims to evaluate
Daniel O'Callaghan, Rory Durand, Colm G. Hanratty, Thomas Cuisset, Beatriz Vaquerizo, Jan‐Malte Sinning, Peter O'Kane, J. J. Coughlan, Simon Walsh, Róisín Colleran, Himanshu Rai, Osama Soliman, Emanuele Barbato, Barbara E. Stähli, Robert A. Byrne   +14 more
wiley   +1 more source

Impact of incomplete percutaneous revascularization in patients With multivessel coronary artery disease: a systematic review and meta-analysis [PDF]

, 2016
Background: Up to half of patients undergoing percutaneous coronary intervention have multivessel coronary artery disease (MVD) with conflicting data regarding optimal revascularization strategy in such patients.
Bagur, Rodrigo, Berry, Colin, Curzen, Nick, De Belder, Mark, Kwok, Chun Shing, Large, Adrian, Ludman, Peter, Mamas, Mamas A., Matsukage, Takashi, Nagaraja, Vinayak, Nolan, James, Ooi, Sze-Yuan, Yoshimachi, Fuminobu   +12 more
core   +2 more sources

A-19 | Abbreviated Versus Prolonged Dual Antiplatelet Therapy (DAPT) Following Percutaneous Coronary Intervention (PCI) with Drug-Eluting Stents (DES): A Meta-Analysis of Randomized Controlled Trials (RCTs) [PDF]

, 2022
Abdulbaril Olagunju, Jumanah Abuasbeh, Ayman R. Fath, Ali Moradi, Ross Johnson, Zachary Lebaron, Mehrdad Saririan   +6 more
openalex   +1 more source

Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Percutaneous coronary intervention (PCI) after transcatheter aortic valve replacement (TAVR) has gained interest as concomitant coronary artery disease (CAD) is now often treated conservatively before TAVR, and TAVR is increasingly used in younger patients with longer life expectancies. Therefore, more contemporary data on PCI after
Hugo M. Aarts, Kimberley I. Hemelrijk, Gijs M. Broeze, Steven A. Muller, Lineke Derks, Ronak Delewi, Michiel Voskuil, the Transcatheter Heart Intervention and Percutaneous Coronary Intervention registration committees of the Netherlands Heart Registration   +7 more
wiley   +1 more source

Multifunctional star-shaped polylactic acid implants for use in angioplasty [PDF]

, 2014
Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Kiran, M. S., Nagarajan, Selvaraj, Reddy, Boreddy Siva Rami, Tsibouklis, John   +3 more
core   +2 more sources

Treatment of Coronary Perforation in a Bifurcation: Two‐Stent Strategies With Fenestrated Covered Stents

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary perforations are a dreaded complication for any interventional cardiologist. The treatment of this complication is exceptionally difficult when it occurs in a coronary bifurcation. While a conservative approach or a balloon occlusion might be sufficient in some cases, additional treatment is sometimes necessary.
Jakob U. Lindner, Janine Pöss, Holger Thiele, Dmitry S. Sulimov   +3 more
wiley   +1 more source

Use of bioresorbable vascular scaffold : a meta-analysis of patients with coronary artery disease [PDF]

, 2016
BACKGROUND: Differences in outcomes between bioresorbable vascular scaffold (BVS) systems and drug-eluting metal stents (DES) have not been fully evaluated.
Akhtar, Zaki, Farag, Mohamed, Gorog, Diana A, Kukreja, Neville, Prasad, Abhiram, Spinthakis, Nikolaos, Srinivasan, Manivannan, Sullivan, Keith   +7 more
core   +2 more sources

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept

Indian Heart Journal, 2014
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is still not well defined. Various treatment modalities include plain old balloon angioplasty (POBA), metallic stent, cutting or scoring balloon and drug ...
Surender Deora, Sanjay Shah, Samir Pancholy, Tejas Patel   +3 more
doaj   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source